Halter Ferguson Financial Inc. Buys 584,818 Shares of Oscar Health, Inc. $OSCR

Halter Ferguson Financial Inc. grew its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 93.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 1,211,825 shares of the company’s stock after buying an additional 584,818 shares during the quarter. Oscar Health makes up 6.5% of Halter Ferguson Financial Inc.’s holdings, making the stock its 7th biggest holding. Halter Ferguson Financial Inc.’s holdings in Oscar Health were worth $37,373,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Nisa Investment Advisors LLC raised its position in shares of Oscar Health by 104.1% in the 3rd quarter. Nisa Investment Advisors LLC now owns 16,812 shares of the company’s stock worth $518,000 after buying an additional 8,576 shares during the period. Revisor Wealth Management LLC acquired a new position in Oscar Health in the third quarter valued at $204,000. Genesee Capital Advisors LLC boosted its holdings in Oscar Health by 227.8% in the third quarter. Genesee Capital Advisors LLC now owns 44,338 shares of the company’s stock valued at $1,367,000 after acquiring an additional 30,814 shares during the last quarter. Abel Hall LLC grew its position in Oscar Health by 4.0% during the third quarter. Abel Hall LLC now owns 10,376 shares of the company’s stock valued at $320,000 after acquiring an additional 400 shares during the period. Finally, Vontobel Holding Ltd. purchased a new stake in Oscar Health during the third quarter valued at about $524,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on OSCR shares. Piper Sandler restated an “overweight” rating and set a $48.00 price target on shares of Oscar Health in a research note on Thursday, September 17th. Raymond James Financial raised their price objective on Oscar Health from $34.00 to $42.00 and gave the stock an “outperform” rating in a report on Friday, September 18th. Weiss Ratings raised Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Bank of America boosted their target price on Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a report on Thursday, September 17th. Finally, Barclays boosted their target price on Oscar Health from $39.00 to $49.00 and gave the stock an “overweight” rating in a report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $34.90.

Oscar Health Price Performance

Oscar Health stock opened at $33.48 on Thursday. The firm has a fifty day moving average of $31.76 and a 200-day moving average of $27.17. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $35.01. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $10.33 billion, a P/E ratio of 23.91, a PEG ratio of 0.37 and a beta of 2.47.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. During the same quarter in the previous year, the business posted ($0.89) EPS. The business’s quarterly revenue was up 70.4% on a year-over-year basis. As a group, analysts predict that Oscar Health, Inc. will post 1.83 EPS for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Vanessa Wittman sold 25,000 shares of the firm’s stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $32.24, for a total value of $806,000.00. Following the transaction, the director directly owned 112,121 shares of the company’s stock, valued at $3,614,781.04. This trade represents a 18.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mario Schlosser sold 31,422 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $988,221.90. Following the transaction, the director owned 449,444 shares in the company, valued at approximately $14,135,013.80. This represents a 6.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 874,451 shares of company stock worth $26,761,671 in the last quarter. 22.64% of the stock is owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.